Mr Chatfield most recently served as the director of the US Selective Service System from November of 2004 to May 2009, having been nominated by president George Bush and confirmed by the US senate. Mr Chatfield was directly responsible to the president for the management of the Selective Service System.
Mr Eckert was chairman, CEO and partner at Boehme Filatex of Reidsville, North Carolina from 1981 to 2007. Mr Eckert started the specialty chemical company with two partners in 1981.
Chris Stern, chairman and CEO of Oxygen Biotherapeutics, said: "I'm very pleased that these two gentlemen have agreed to join our board. Rene Eckert has the business acumen and experience in product R & D, production scale up, and product manufacturing to help us bring Oxycyte-based products to the market.
"What Bill Chatfield brings to the table is the kind of federal government experience and contacts, including the Department of Defense, that can be very helpful as we grow our Defense Medicine business plan. Our board and company will be stronger with their involvement."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index